Japan Animal Referral Medical, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 20%, Raises Record High Profit Forecast
6039 Japan Animal Referral Medical Center Co.,Ltd. 【J-GAAP】
Earnings ReportJapan Animal Referral Medical Center Co.,Ltd. <6039> [TSE Growth] announced its financial results after the market closed on November 13th (15:30). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending March 2026 (April to September) expanded 0.58 billion yen, an increase 67.8% compared to the same period last year.
In addition, the full-year forecast for consolidated ordinary profit has been revised upward 20.2%, from the previous forecast of 0.85 billion yen to 1.03 billion yen (compared to 0.72 billion yen in the previous period), increasing the growth rate from 19.0% to 43.1%, further surpassing the previous forecast of record-high profits for two consecutive terms.
Based on the first-half performance announced by the company and the full-year plan, our calculation indicates that the consolidated ordinary profit for the October to March period (second half) is expected to grow 19.5% from the same period last year, reaching 0.44 billion yen.
In the most recent three-month period, from July to September (2Q), the consolidated ordinary profit increased 64.7% from the same period last year, reaching 0.33 billion yen. The operating profit margin jumped from 15.2% in the same period last year to 21.3%.
Kabutan News
Actual Performance and Financial Trends
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Progress Rate vs. First Half |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
1,982M | 159M | 152M | 97M | 7.1 | 31.1 | Nov 9, 2023 | J-GAAP |
|
|
2,569M | 350M | 351M | 242M | 18.7 | 48.8 | Nov 7, 2024 | J-GAAP |
|
|
3,033M | 591M | 589M | 413M | 32.0 | 57.2 | Nov 13, 2025 | J-GAAP |
| YoY | +18.1% | +68.9% | +67.8% | +70.7% | +70.9% |
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2025 Guidance | ー | ー | ー | ー | － | 0 | May 15, 2025 | J-GAAP |
| Apr - Sep, 2025 Results | 3,033M | 591M | 589M | 413M | 32.0 | 0 | Nov 13, 2025 | J-GAAP |
| Revision Rate | － | － | － | － | － |
Guidance Update
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2026 Prev | 5,960M | 857M | 857M | 610M | 47.2 | 8 | Aug 14, 2025 | J-GAAP |
| Mar, 2026 New | 6,100M | 1,040M | 1,030M | 730M | 56.5 | 8 | Nov 13, 2025 | J-GAAP |
| Revision Rate | +2.3% | +21.4% | +20.2% | +19.7% | +19.7% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
2,708M | 370M | 369M | 278M | 21.5 | 7.40 | May 15, 2025 | J-GAAP |
|
Guidance
Oct - Mar, 2025
|
3,067M | 449M | 441M | 317M | 24.5 | 8 | Nov 13, 2025 | J-GAAP |
| YoY | +13.3% | +21.4% | +19.5% | +14.0% | +14.1% |
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
4,270M | 496M | 489M | 337M | 24.6 | 4 | May 9, 2024 | J-GAAP |
|
|
5,277M | 720M | 720M | 520M | 40.2 | 7.40 | May 15, 2025 | J-GAAP |
|
Guidance
Mar, 2026
|
6,100M | 1,040M | 1,030M | 730M | 56.5 | 8 | Nov 13, 2025 | J-GAAP |
| YoY | +15.6% | +44.4% | +43.1% | +40.4% | +40.4% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Operating Profit Margin |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
1,319M | 201M | 201M | 139M | 10.8 | 15.2 | Nov 7, 2024 | J-GAAP |
|
|
1,373M | 240M | 239M | 167M | 12.9 | 17.5 | Feb 14, 2025 | J-GAAP |
|
|
1,335M | 130M | 130M | 111M | 8.6 | 9.7 | May 15, 2025 | J-GAAP |
|
|
1,473M | 258M | 258M | 180M | 14.0 | 17.5 | Aug 14, 2025 | J-GAAP |
|
|
1,560M | 333M | 331M | 233M | 18.0 | 21.3 | Nov 13, 2025 | J-GAAP |
| YoY | +18.3% | +65.7% | +64.7% | +67.6% | +67.8% |
Related Articles
-
MarkLines, Jan-Sep (Cumulative 3Q) Ordinary Profit Decreases by 1%
Thu Nov 13, 2025 3:30 pm JST Earnings -
sinops, Jan-Sep (Cumulative 3Q) Ordinary Profit Increases by 3.3 times
Thu Nov 13, 2025 3:30 pm JST Earnings -
Sanyo Electric Railway, Ordinary Profit Forecast for the Fiscal Year Revised Upward to an Unexpected 2% Increase, Dividend Revised Upward by 10 Yen
Thu Nov 13, 2025 3:30 pm JST Earnings -
logly, First Half Ordinary Profit Loss Narrows, Jul-Sep Ordinary Profit Loss Narrows
Thu Nov 13, 2025 3:30 pm JST Earnings -
CAPITA, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 6%, Dividend Revised Upward by 6 Yen
Thu Nov 13, 2025 3:30 pm JST Earnings -
Noile-Immune Biotech, The Current Fiscal Year's Undisclosed Net Income to Narrow
Thu Nov 13, 2025 3:30 pm JST Earnings -
SPRIX, 13% Increase in Ordinary Profit for The Current Fiscal Year
Thu Nov 13, 2025 3:30 pm JST Earnings -
ITFOR, First Half Ordinary Profit Revised Downward to an Unexpected 21%Decrease, Current Fiscal Year Dividend Revised Upward by 20 Yen
Thu Nov 13, 2025 3:30 pm JST Earnings -
Jibannet, First Half Net Income Turns to Loss, Jul-Sep Net Income Decreases by 40%
Thu Nov 13, 2025 3:30 pm JST Earnings -
FRUTA FRUTA, First Half Ordinary Profit Increases by 3.7 times, Jul-Sep Ordinary Profit Increases by 40%
Thu Nov 13, 2025 3:30 pm JST Earnings